Medyria

Medyria

HealthWinterthur, Switzerland

Medyria is a Swiss medical technology pioneer specializing in invasive coronary diagnostics. The company develops blood-flow-velocity sensors and catheter technologies, with its lead product, PyCath, designed to measure blood flow velocity during interventional cardiology procedures.

🏆 Featured in Datapile’s Q3 2026 Switzerland Funding Report

Read the Q3 2026 Switzerland report →
Add this badge to your site
<a href="https://datapile.co/reports/q3-2026-switzerland-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q3 2026 Switzerland Funding Report</a>

Funding history

  1. $3.9M2026-07-24
    Source: news.google.com

Founder

Mauro M. Sette
Mauro M. Sette
CEO

More Health companies

Recently funded startups in the same category.

Related on Datapile